|
|
|
Insider
Information: |
Lamothe Jeffrey G. |
Relationship: |
|
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
37,504 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,853 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
37,504 |
|
|
Total
Value |
$4,853 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aptevo Therapeutics Inc. |
APVO |
|
2024-03-03 |
37,504 |
2017-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
APVO |
Aptevo Therapeutics Inc. |
EVP, COO |
|
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,667 |
37,504 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
EVP, COO |
|
2024-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
33,837 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
EVP, COO |
|
2024-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,833 |
28,337 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
EVP, COO |
|
2023-08-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,812 |
26,504 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
EVP, COO |
|
2023-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,666 |
12,692 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
CFO |
|
2023-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,834 |
9,026 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP and CFO |
|
2022-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,833 |
7,192 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP and CFO |
|
2019-03-01 |
4 |
D |
$1.57 |
$3,407 |
D/D |
(2,170) |
75,024 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP and CFO |
|
2019-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,318 |
77,194 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2018-03-10 |
4 |
D |
$3.13 |
$4,955 |
D/D |
(1,583) |
69,876 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,747 |
71,459 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2018-03-01 |
4 |
D |
$3.04 |
$5,220 |
D/D |
(1,717) |
64,712 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,320 |
66,429 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2018-02-03 |
4 |
D |
$3.24 |
$24,345 |
D/D |
(7,514) |
59,109 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2018-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,340 |
66,623 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2017-03-10 |
4 |
D |
$1.78 |
$12,060 |
D/D |
(6,775) |
41,284 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,863 |
46,274 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,066 |
29,196 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2017-03-01 |
4 |
D |
$2.02 |
$3,911 |
D/D |
(1,936) |
22,450 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2017-02-03 |
4 |
D |
$1.92 |
$15,886 |
D/D |
(8,274) |
17,066 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
SVP, CFO and Treasurer |
|
2017-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,340 |
25,340 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|